Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Durol, ALB Daily, JP Graf, JA Mertzanis, P Hoffman, JL Shader, RI

Citation: Dj. Greenblatt et al., Differential impairment of triazolam and zolpidem clearance by ritonavir, J ACQ IMM D, 24(2), 2000, pp. 129-136

Authors: von Moltke, LL Durol, ALB Duan, SX Greenblatt, DJ

Citation: Ll. Von Moltke et al., Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole, EUR J CL PH, 56(3), 2000, pp. 259-261

Authors: Greenblatt, DJ Harmatz, JS von Moltke, LL Wright, CE Durol, ALB Harrel-Joseph, LM Shader, RI

Citation: Dj. Greenblatt et al., Comparative kinetics and response to the benzodiazepine agonists triazolamand zolpidem: Evaluation of sex-dependent differences, J PHARM EXP, 293(2), 2000, pp. 435-443

Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Durol, ALB Daily, JP Graf, JA Mertzanis, P Hoffman, JL Shader, RI

Citation: Dj. Greenblatt et al., Alprazolam-ritonavir interaction: Implications for product labeling, CLIN PHARM, 67(4), 2000, pp. 335-341

Authors: Kotegawa, T Laurijssens, BE Durol, ALB Greenblatt, DJ

Citation: T. Kotegawa et al., Pharmacokinetics and electroencephalographic effects of ketoconazole in the rat, BIOPHARM DR, 20(1), 1999, pp. 49-52

Authors: Greenblatt, DJ von Moltke, LL Harmatz, JS Mertzanis, P Graf, JA Durol, ALB Counihan, M Roth-Schechter, B Shader, RI

Citation: Dj. Greenblatt et al., Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole, CLIN PHARM, 64(6), 1998, pp. 661-671